Current Opinion in Gastroenterology

Papers
(The TQCC of Current Opinion in Gastroenterology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The utility of liver biopsy in 202084
Panorama of mediators in postpancreatitis diabetes mellitus39
Metabolic dysfunction-associated fatty liver disease: a year in review37
Gaining resilience and reducing stress in the age of COVID-1936
Peutz-Jeghers syndrome35
New targets in inflammatory bowel disease therapy: 202133
Gut microbiota and sepsis: from pathogenesis to novel treatments31
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems31
Radiation enteritis: from diagnosis to management30
Update on chronic intestinal pseudo-obstruction29
Opioid-induced esophageal dysfunction25
The burden of cost in inflammatory bowel disease: a medical economic perspective24
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections22
Autoimmune pancreatitis type 222
Role of gut–kidney axis in renal diseases and IgA nephropathy20
Early detection of pancreatic cancer20
Primary biliary cholangitis: pathogenic mechanisms20
Protein-losing enteropathy20
Advances in the treatment of gastric cancer: 2020–202120
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease19
The prevention of gastric cancer by Helicobacter pylori eradication19
Gastrointestinal symptoms in COVID-19: the long and the short of it19
Intravenous fluid resuscitation in the management of acute pancreatitis18
Diabetes in chronic pancreatitis: risk factors and natural history18
Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum?17
Diet and cancer of the esophagus and stomach17
Integration of telemedicine into clinical practice for inflammatory bowel disease15
Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract – a systematic review15
Primary biliary cholangitis: treatment15
Tracking COVID-19 via sewage15
New systemic agents for hepatocellular carcinoma: an update 202015
The rise of antibiotic resistance in Campylobacter14
Bone loss in patients with inflammatory bowel disease: cause, detection and treatment14
Endoscopic eradication therapy for Barrett's oesophagus: state of the art14
The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice13
Robotics in flexible endoscopy: current status and future prospects13
EsoFLIP for esophageal dilation: proposed advantages13
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies13
Can SARS-CoV-2 be transmitted via faeces?13
Approaches to diet therapy for eosinophilic esophagitis13
Advances in cirrhotic cardiomyopathy13
Dysregulated lipid metabolism in colorectal cancer12
Advancing flexible endoscopy to natural orifice transluminal endoscopic surgery12
Diet and carcinogenesis of gastric cancer12
Endoscopic diagnosis and management of gastric subepithelial lesions12
Hepatic manifestations of cystic fibrosis11
The role of bariatric surgery in the management of nonalcoholic steatohepatitis11
Mesenchymal stem cell therapy for liver disease: current status and future perspectives11
The potential of microbiome replacement therapies for Clostridium difficile infection11
The impact of inflammatory bowel disease on women's lives11
Coronavirus disease-2019: implications for the gastroenterologist10
Single-use duodenoscopes: where are we and where are we going?10
Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus10
Current endoscopic approaches to biliary strictures10
Social media in inflammatory bowel disease: the patient and physician perspective10
Cellular senescence in the cholangiopathies9
Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)9
Advances in the treatment of gastric cancer9
Immunotherapy in cholangiocarcinoma9
Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria9
Novel treatment options for acute hepatic porphyrias9
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?9
Host immune interactions in chronic inflammatory gastrointestinal conditions9
The future of telemedicine and wearable technology in IBD9
The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease9
Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention8
Proton pump inhibitors: misconceptions and proper prescribing practice8
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials8
Signatures in drug-induced liver injury8
Mechanisms of autoimmune hepatitis8
Fatigue in inflammatory bowel disease: a problematic ailment8
Noninvasive strategies for colorectal cancer screening: opportunities and limitations8
Should high-fiber diets be recommended for patients with inflammatory bowel disease?7
Painful chronic pancreatitis - new approaches for evaluation and management7
Nutritional consequences of bariatric surgery – prevention, detection and management7
Impact of bariatric surgery on gastroesophageal reflux disease and esophageal motility7
Early detection of pancreatic cancer: current state and future opportunities7
Celiac disease: clinical update7
Role of albumin in the treatment of decompensated liver cirrhosis7
Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic7
Dietary interventions and irritable bowel syndrome – what really works?7
Multidisciplinary management of perianal Crohn's disease7
Macronutrients, microbiome and precision nutrition7
The treatment approach to inflammatory bowel disease in 20207
How to advise patients on the risk of chronic proton pump inhibitor therapy7
Macrophages in cholangiopathies7
Small bowel radiology7
Refractory coeliac disease: what should we be doing different?6
Management of refractory inflammatory bowel disease6
Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease6
Breath testing for the diagnosis of pancreatic disease6
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging6
Management of regurgitation in patients with gastroesophageal reflux disease6
Drug-induced bile duct injury: new agents, new mechanisms6
Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation6
Impact of gastroesophageal reflux disease on idiopathic pulmonary fibrosis and lung transplant recipients6
Advances in the genetics of nonalcoholic fatty liver disease6
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice6
Endoscopic methods for the detection and treatment of gastric cancer6
Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation6
Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons6
Statins for treatment of chronic liver disease6
Hepatitis E virus: has anything changed?6
Duodenal chemosensory system: enterocytes, enteroendocrine cells, and tuft cells6
Complications of chronic pancreatitis in children6
The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment6
Novel treatments for alcoholic hepatitis6
Third space endoscopy: the future of treating gastrointestinal dysmotility6
Coagulation testing and management in liver disease patients6
Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again6
0.056586027145386